EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Efficacy of Secukinumab in Chinese Patients with Moderate-to-Severe Hidradenitis Suppurativa: A 16-Week, Single-Center, Prospective, Real-World Study

Chao Wu, Xiao Ma iD, Yong-Jun Wang iD, Tie-Jun Liu, Xin-Yuan Zhang, Hong-Zhong Jin

Journal of Inflammation Research · 2026-09 · Volume 19 · 1-13

DOI: 10.2147/jir.s637429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-09. Verfasst von Chao Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medica…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Hidradenitis suppurativaanti-interleukin-17A antibodyefficacysafetysecukinumabtherapeutic effect

Autor:innen und Institutionen

  • Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People's…
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republ…

ORCID-Profile: Xiao Ma, Yong-Jun Wang

Zitieren

APA

Wu, C., Ma, X., Wang, Y. J., Liu, T. J., Zhang, X. Y., & Jin, H. Z. (2026). Efficacy of Secukinumab in Chinese Patients with Moderate-to-Severe Hidradenitis Suppurativa: A 16-Week, Single-Center, Prospective, Real-World Study. Journal of Inflammation Research, Volume 19, 1-13. https://doi.org/10.2147/jir.s637429

Vancouver

Wu C, Ma X, Wang YJ, Liu TJ, Zhang XY, Jin HZ. Efficacy of Secukinumab in Chinese Patients with Moderate-to-Severe Hidradenitis Suppurativa: A 16-Week, Single-Center, Prospective, Real-World Study. Journal of Inflammation Research. 2026;Volume 19:1-13. doi:10.2147/jir.s637429

BibTeX
@article{Wu2026,
  author = {Wu, Chao and Ma, Xiao and Wang, Yong-Jun and Liu, Tie-Jun and Zhang, Xin-Yuan and Jin, Hong-Zhong},
  title = {Efficacy of Secukinumab in Chinese Patients with Moderate-to-Severe Hidradenitis Suppurativa: A 16-Week, Single-Center, Prospective, Real-World Study},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--13},
  doi = {10.2147/jir.s637429}
}
Kostenlos starten →